ArticleCureus2025
Compliance With Iron and Folic Acid Supplements Among Pregnant Women Attending Tertiary Care Hospital in the District of Peshawar.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Acceptability, Adherence, and Provision Through Antenatal Care: Evidence on Multiple Micronutrient Supplementation in Pakistan and Nigeria.Nutrients · 2026Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives This study aimed to determine the level of compliance with iron and folic acid supplementation (IFAS) and identify factors influencing compliance among pregnant women attending tertiary care hospitals in District Peshawar. Methods This cross-sectional study was conducted over a period of two months, from January 15, 2022, to April 30, 2022, among pregnant women visiting tertiary care hospitals in district Peshawar for antenatal checkups. A nonprobability-purposive sampling technique was used to collect the data. Pregnant women in their second and third trimesters were included, while those in the first trimester or with comorbidities were excluded. Data were collected using a validated and reliable questionnaire. Statistical analyses included the Chi-square test, independent t-test, and Fisher's exact test, where appropriate, with a significance level set at p < 0.05. Results The mean age of the study participants was 26.87 ± 6.80 years, with 24% residing in nuclear families. The majority of participants had attained at least a basic level of education. Obstetric history revealed an average of four pregnancies and two deliveries per participant, with 28.61% reporting previous abortions and 21.67% experiencing stillbirths. Antenatal care utilization was high, with 98% receiving prenatal care, while 52.78% had a documented history of anemia. Regarding IFAS compliance, only 34.4% of the participants met the adherence criteria. The primary motivators for compliance included encouragement from healthcare workers and fear of pregnancy-related complications. Conversely, forgetfulness and concerns about potential side effects were the most commonly cited barriers to adherence. Demographic factors associated with IFAS compliance included age, place of residence, family structure, participant's education, spouse's education, and median monthly income. In addition, pregnancy-related factors such as parity, total number of prenatal visits, gestational age at the initial visit, and the duration of supplement use during the current pregnancy were significantly associated with compliance. Multivariate logistic regression identified nuclear family structure as a significant predictor of lower compliance (OR = 0.513, 95% CI: 0.30-0.878, p = 0.015). Similarly, participants who took IFAS for only one month during pregnancy were significantly less likely to comply (OR = 0.246, 95% CI: 0.082-0.736, p = 0.012). Conclusion Low levels of compliance with iron and folic acid supplements were noted, highlighting a significant challenge. Family structure and the duration of IFAS intake during pregnancy play crucial roles in predicting compliance among pregnant women. Healthcare worker encouragement and addressing concerns about negative effects may enhance compliance. Interventions should be tailored to address these factors, which require immediate attention and resolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.